Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health (NYSE: CVS) announced that CFO Shawn Guertin will participate in a fireside chat at the 31st Annual Credit Suisse Healthcare Conference on November 9, 2022, at 8:35 am PT. The event will be accessible via an audio webcast on the CVS Health Investor Relations site, where it will be archived for one year.
CVS Health reports Q3 2022 results, revealing total revenues of $81.2 billion, a 10% increase year-over-year. The company faced a GAAP loss of $(2.60) per share due to $5.2 billion in opioid litigation charges. Adjusted EPS stood at $2.09, with revised full-year GAAP EPS guidance now at $3.12 to $3.22. Increased revenues in Health Care Benefits and Pharmacy Services segments offset losses in Retail/LTC. The company also announced plans to acquire Signify Health for approximately $8 billion.
CVS Health (NYSE: CVS) has reached an agreement in principle to resolve opioid-related lawsuits and claims with states and tribes across the U.S. The company plans to pay approximately $5 billion over the next decade, with $4.9 billion allocated to states and local governments, and $130 million to tribes. This settlement will fully resolve claims dating back over ten years and is not an admission of liability. CVS continues to defend against unresolved litigation while reinforcing its commitment to combat opioid misuse through various community initiatives and investments.
CVS Health has published a report indicating that 61% of adults desire a broader range of health services from local pharmacies. Conducted in collaboration with Morning Consult, the survey reflects increased consumer trust in pharmacists, with 74% supporting their role in healthcare when primary care is unavailable. The report emphasizes the importance of empowering CVS's 30,000 pharmacists to enhance patient care, particularly in light of their critical involvement during the COVID-19 pandemic. The findings underscore a significant opportunity for CVS to innovate in service delivery and patient engagement.
CVS Health is launching the Aetna Connected Plan in the metro Atlanta area, combining Aetna Whole Health and CVS services to provide a more affordable healthcare option. The plan aims to enhance access to care through CVS Pharmacy and MinuteClinic locations, emphasizing convenience for mid-sized businesses, which could see up to 15% savings. This network includes various in-network providers, with features like $0 copays for certain services, 90-day prescription refills, and home delivery options. Available in select counties, this innovative model focuses on improving healthcare outcomes for members.
CVS Health will host a conference call with analysts on November 2, 2022, at 8:00 a.m. ET to discuss its third quarter 2022 financial results. The call will be accessible via an audio webcast on the company's Investor Relations website, where it will remain archived for one year. CVS Health is recognized as a leading health solutions provider, committed to enhancing community health through a vast network of services, including over 300,000 employees and 40,000 healthcare professionals.
CVS Health® announced the appointment of Dr. Amar Desai as President of the newly formed Health Care Delivery organization, effective October 17. Dr. Desai, formerly CEO of Optum Pacific West, will direct CVS Health's clinical delivery strategy, focusing on retail health, chronic disease management, and behavioral health. This strategic move aims to enhance the company's health services while leveraging its extensive portfolio. CEO Karen S. Lynch emphasized Dr. Desai's clinical expertise as vital for delivering high-quality care to patients.
Aetna, a CVS Health company, has unveiled its 2023 Medicare plans focusing on affordability and enhanced benefits for members. Key highlights include Medicare Advantage plans with $0 premiums available to 84% of beneficiaries, new Dual Eligible Special Needs Plans, and expanded options for veterans. Aetna will also implement significant cost reductions in prescription drug coverage, including $0 deductibles and copays on many medications. The updates aim to relieve financial burdens for older adults while increasing access to essential health services.
CVS Health (NYSE: CVS) is taking significant steps to ensure safety and continuity of care as Hurricane Ian approaches Florida. The company is proactively reaching out to patients regarding medication refills and supplying stores with emergency items. Key measures include offering emergency refills for plan members and expanding support for Medicare and Commercial members. CVS Pharmacy will comply with local evacuation orders and has strategies in place for rerouting calls from closed pharmacies. The company emphasizes the importance of preparedness for its customers and communities during the storm.
CVS Health has reported significant progress in its goal to reduce suicide attempts among Aetna members by 20% by 2025, achieving a 15.7% reduction as of March 2022 compared to 2019 baselines. For adults aged 18+, there was a 34.1% decrease in attempts, while the rate among adolescents (ages 13-17) unfortunately rose by 32%. CVS attributes this progress to various initiatives, including its Adolescent Outreach Program and partnerships aimed at providing necessary mental health resources.